Therefore, MLXIPL/ChREBP mediates conversion of sugars into lipids [34], as confirmed by studies in ChREBP knockout mice showing elevated circulating glucose and insulin levels and reduced fatty acid and increased glycogen liver content [35], consistent with the low triglyceride levels and normal lipid profile observed in WS patients. This evidence concerns the gene INS and Werner syndrome.